Back to search
Incomplete Reversal of Neuromuscular Block
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Incomplete Reversal of Neuromuscular Block trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Incomplete Reversal of Neuromuscular Block trials you may qualify forThis study will compare patient recovery measures after reversal of neuromuscular blockade with neostigmine or sugammadex after surgery. Measures include pulmon…
The purpose of this study is to determine the minimum effective dose of sugammadex, an antagonist of neuromuscular blockade used during anesthesia practice, in…
The purpose of this study is to determine whether dexamethasone extends the duration of recovery from anesthesia.
Residual neuromuscular block (RNMB) is frequent in the immediate postoperative period and is a source of complications, mainly respiratory. The incidence is var…